WHO ICTRP trial
Evaluation of the necessary frequency of blood glucose self-monitoring in type 2…
ISRCTN79164268 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN79164268 |
|---|---|
| Public title | Evaluation of the necessary frequency of blood glucose self-monitoring in type 2 diabetic patients. A prospective, controlled, randomised, multicenter study. |
| Primary sponsor | Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Germany |
| Conditions | Type 2 diabetes mellitus Nutritional, Metabolic, Endocrine Diabetes |
| Interventions | Blood glucose monitoring 1. Patients on insulin mixture: 1.1 Maximum recommendation: every day fasting, every second day before dinner, additional once a profile 1.2 Minimum recommendation: once a week a fasting blood glucose 2. Patients… |
| Registration date | Oct 28, 2005 |
| Target size | 400 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: